1. Home
  2. Animal Drug Index - R
  3. Renakare

Animal NDC 59051-9074-5 Renakare

Potassium Gluconate

Animal Product Information

Field Name Field Value
Animal NDC Code 59051-9074-5
Proprietary Name Renakare What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Potassium Gluconate What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Neogen Corporation-mercer
Product Type Prescription Animal Drug
Usage Information
    For use as a potassium supplement in hypokalemic cats and dogs.
Active Ingredient(s)
  • Potassium Gluconate
Marketing Category UNAPPROVED DRUG OTHER What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Renakare Images

Renakare Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Each Tablet Contains (Minimum):



Potassium gluconate.........2 mEq (468 mg)


Dosage:



Adult cats and dogs...2 mEq/4.5 kg (1 tablet/10 lb) PO BID

Kittens and puppies.............................consult veterinarian

Administer with food. Dosage may be adjusted as necessary by the veterinarian.


Warnings:



May cause hyperkalemia. Do not exceed the recommended dose. Frequent patient monitoring is advised. Adverse effects include gastrointestinal irritation, muscular weakness, twitching, irritability, and cardiac conduction disturbances. Postassium salts are contraindicated in animals with hyperkalemia, severe renal impairment or failure, severe hemolytic reactions, Addison's disease, decreased gastrointestinal motility, and acute dehydration.


Precautions:



Use with caution in animals receiving digoxin, potassium-sparing diuretics, ACE inhibitors, and NSAIDs.


Indications:



For use as a potassium supplement in hypokalemic cats and dogs.


Principal Display Panel - 100 Tablet Bottle



NDC: 59051-9074-5

RenaKare

Potassium gluconate tablets

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Net Contents: 100 Tablets


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.